Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression.

Hicks JA, Argyropoulos SV, Rich AS, Nash JR, Bell CJ, Edwards C, Nutt DJ, Wilson SJ.

Br J Psychiatry. 2002 Jun;180:528-35.

2.
3.

Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.

Rush AJ, Armitage R, Gillin JC, Yonkers KA, Winokur A, Moldofsky H, Vogel GW, Kaplita SB, Fleming JB, Montplaisir J, Erman MK, Albala BJ, McQuade RD.

Biol Psychiatry. 1998 Jul 1;44(1):3-14.

PMID:
9646878
4.

A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.

Gillin JC, Rapaport M, Erman MK, Winokur A, Albala BJ.

J Clin Psychiatry. 1997 May;58(5):185-92. Erratum in: J Clin Psychiatry 1997 Jun;58(6):275.

PMID:
9184611
5.

Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.

Argyropoulos SV, Hicks JA, Nash JR, Bell CJ, Rich AS, Nutt DJ, Wilson S.

J Sleep Res. 2009 Sep;18(3):342-8. doi: 10.1111/j.1365-2869.2008.00724.x. Epub 2009 Jun 22.

6.

A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.

Baldwin DS, Hawley CJ, Abed RT, Maragakis BP, Cox J, Buckingham SA, Pover GH, Ascher A.

J Clin Psychiatry. 1996;57 Suppl 2:46-52.

PMID:
8626363
7.
8.

The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.

Manber R, Rush AJ, Thase ME, Amow B, Klein D, Trivedi MH, Korenstein SG, Markowitz JC, Dunner DL, Munsaka M, Borian FE, Martin, Keller B.

Sleep. 2003 Mar 15;26(2):130-6.

PMID:
12683470
9.

Correlation of subjective and objective sleep measurements at different stages of the treatment of depression.

Argyropoulos SV, Hicks JA, Nash JR, Bell CJ, Rich AS, Nutt DJ, Wilson SJ.

Psychiatry Res. 2003 Sep 30;120(2):179-90. Review.

PMID:
14527649
11.
12.
13.

Paroxetine, a selective serotonin reuptake inhibitor, reduces depressive symptoms and subjective handicaps in patients with dizziness.

Horii A, Mitani K, Kitahara T, Uno A, Takeda N, Kubo T.

Otol Neurotol. 2004 Jul;25(4):536-43.

PMID:
15241233
14.

Evaluation of sleep architecture and cyclic alternating pattern rates in depressed insomniac patients treated with nefazodone hydrochloride.

Scharf MB, McDannold M, Zaretsky N, Spinner O, Stover R, Berkowitz DV, Conrad C.

Am J Ther. 1999 Mar;6(2):77-82.

PMID:
10423649
15.

The effects of paroxetine and nefazodone on sleep: a placebo controlled trial.

Sharpley AL, Williamson DJ, Attenburrow ME, Pearson G, Sargent P, Cowen PJ.

Psychopharmacology (Berl). 1996 Jul;126(1):50-4.

PMID:
8853216
16.

Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.

Davis R, Whittington R, Bryson HM.

Drugs. 1997 Apr;53(4):608-36. Review.

PMID:
9098663
17.

Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability.

Rickels K, Schweizer E, Case WG, DeMartinis N, Greenblatt DJ, Mandos LA, Garcia EspaƱa FG.

J Clin Psychopharmacol. 1998 Apr;18(2):145-53.

PMID:
9580369
18.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
19.
20.

A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome.

Mulsant BH, Pollock BG, Nebes RD, Miller MD, Little JT, Stack J, Houck PR, Bensasi S, Mazumdar S, Reynolds CF 3rd.

J Clin Psychiatry. 1999;60 Suppl 20:16-20.

Supplemental Content

Support Center